Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2017

View Archived Issues

BeiGene begins phase III study of BGB-3111

ConverGene enters research agreement with University of Maryland to evaluate drugs for leukemia

GlaxoSmithKline studies GSK-3117391 for rheumatoid arthritis in phase II trial

FDA approves new dosage strength of Linzess for CIC

Pfizer's C. difficile vaccine shows promising results in interim analysis of phase II study

X4 Pharmaceuticals starts phase I/II study of X4P-001 plus nivolumab in RCC

European Commission approves update to Jardiance label

Cellecta receives grant from NIH to advance CRISPR/Cas9 library technology

Exemplar Genetics contracted to create models of sickle cell disease

Pilot study result for ICMT-11 radiotracer for the assessment of apoptosis in AD

Johnson & Johnson announces highlights of fourth quarter 2016

Fruquintinib combined with paclitaxel in phase I/II gastric cancer trial

Bristol-Myers Squibb reflects on accomplishments of fourth quarter 2016

Phase II study reveals fosbretabulin activity in neuroendocrine tumors

Foresee announces topline results from phase III trial of FP-001 LMIS in advanced prostate cancer

ImmunoGen initiates phase I study of mirvetuximab soravtansine for platinum-resistant ovarian cancer

Acucela initiates phase IIa study of emixustat in macular atrophy secondary to Stargardt's disease

Jiangsu Chia Tai Tianqing, Centaurus BioPharma and Lianyungang Ruzhong patent EGFR mutant inhibitors

OncBioMune updates data from phase I trial of ProscaVax

Yokohama City University and QST divulge new AMPA receptor ligands

Tohoku University develops T-type calcium channel enhancer with potential for Alzheimer's disease

Deinobiotics identifies novel antibacterial bicyclic lipolantipeptides

CSIC, Universidad Miguel Hernandez disclose TRPM8 antagonists

Mitsubishi Tanabe and Biogen terminate MT-1303 license agreement

Tumoral caveolin-1 expression linked to gastric cancer progression

Eli Lilly terminates collaboration with Adocia on BioChaperone Lispro

Vicore Pharma's C-21 receives FDA orphan designation for idiopathic pulmonary fibrosis

Shionogi reports phase III data on S-524101 for house dust mite allergic rhinitis in children

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...